SimpleScience@Heart: New diabetes drug may prevent brain swelling after stroke
A new version of the diabetes drug glyburide may help prevent deadly brain swelling in patients with a devastating stroke.
During a stroke, fluid can build up in the brain when a clot blocks one of the large arteries of the brain. The fluid causes extreme swelling and brain tissue shifts that can be deadly. The only proven treatment is surgery to open the skull and relieve the swelling.
In a preliminary study, researchers injected the new drug in 10 patients at risk of the swelling. Two of the patients still developed the condition. Typically, about nine out of 10 similar stroke patients who don’t receive the drug develop brain swelling.
Researchers said more trials are needed to better understand the safety and value of the drug.
Stories available for linking, quoting, excerpting, reprinting
Stories appearing on blog.heart.org under the "By American Heart Association News" byline are available for linking, quoting, excerpting and reprinting. Copyright is owned or held by the American Heart Association, Inc., and all rights are reserved. Permission is granted, at no cost and without need for further request, to link to, quote, excerpt or reprint from these stories in any medium as long as no text is altered and proper attribution is made to the American Heart Association. Additional conditions may apply to the use of these stories in printed materials.Stories appearing under the American Heart Association News byline are news articles. The stories are informative and timely and do not always represent the views of the American Heart Association.